Science Explorer Back to mapMap

Pharmaceutical Economics and Policy

Pharmaceutical Economics and Policy is a research topic within Economics and Econometrics. Science Explorer counts 28k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the economics of pharmaceutical research and development, focusing on topics such as drug development costs, generic drugs, pharmaceutical innovation, medicine prices, patent expiry, healthcare policies, market size, availability of medicines, and generic substitution.

  • Drug Development Costs
  • Generic Drugs
  • Pharmaceutical Innovation
  • Medicine Prices
  • Patent Expiry
  • Healthcare Policies
  • Market Size
  • Availability of Medicines
  • Generic Substitution
  • Pharmaceutical Industry
Research works
28k
fractional, since 1950
In the world top 10%
2.9k
per year above
Top-10% rate
10.3%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+6%
the tick is no change
Largest producer
United States
41% of the 10 largest, 2022-now
Pharmaceutical Economics and Policy
Drawing this view